OTC Markets OTCPK - Delayed Quote USD

Clarity Pharmaceuticals Ltd (CLRPF)

1.5500
0.0000
(0.00%)
At close: May 9 at 4:00:00 PM EDT
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
Operating Expense
56,307.3220
56,307.3220
36,164.0620
30,290.9690
Operating Income
-56,307.3220
-56,307.3220
-36,164.0620
-30,290.9690
Net Non Operating Interest Income Expense
2,771.3800
2,771.3800
1,864.2600
95.0930
Other Income Expense
11,506.6650
11,506.6650
9,800.5560
6,458.9250
Pretax Income
-42,029.2770
-42,029.2770
-24,499.2460
-23,736.9510
Tax Provision
295.1510
295.1510
103.2000
17.6320
Net Income Common Stockholders
-42,324.4280
-42,324.4280
-24,602.4460
-23,754.5830
Basic EPS
-0.15
--
-0.09
-0.10
Diluted EPS
-0.15
--
-0.09
-0.10
Basic Average Shares
273,158.1890
--
260,410.3370
248,465.0600
Diluted Average Shares
273,158.1890
--
260,410.3370
248,465.0600
Net Income from Continuing & Discontinued Operation
-42,324.4280
-42,324.4280
-24,602.4460
-23,754.5830
Normalized Income
-42,324.4280
-42,324.4280
-24,602.4460
-23,754.5830
Interest Income
2,771.3800
2,771.3800
1,864.2600
95.0930
Net Interest Income
2,771.3800
2,771.3800
1,864.2600
95.0930
EBIT
-56,307.3220
-56,307.3220
-36,164.0620
-30,290.9690
EBITDA
-56,154.2540
-56,154.2540
-36,063.5490
-30,244.7200
Reconciled Depreciation
153.0680
153.0680
100.5130
46.2490
Net Income from Continuing Operation Net Minority Interest
-42,324.4280
-42,324.4280
-24,602.4460
-23,754.5830
Normalized EBITDA
-56,154.2540
-56,154.2540
-36,063.5490
-30,244.7200
Tax Rate for Calcs
0.0003
0.0003
0.0003
0.0003
Tax Effect of Unusual Items
0
0
0
0
6/30/2022 - 8/15/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TLPPF Telix Pharmaceuticals Limited
17.88
0.00%
 
ALVIO.PA Valerio Therapeutics Société anonyme
0.0635
+1.93%
 
RADX Radiopharm Theranostics Limited
4.1800
+2.96%
 
MOLN Molecular Partners AG
4.1000
-0.97%
 
TLX Telix Pharmaceuticals Limited
17.18
+0.76%
 
PHGE BiomX Inc.
0.5160
-7.38%
 
CLRB Cellectar Biosciences, Inc.
0.2474
-1.63%
 
ENTX Entera Bio Ltd.
2.1500
-3.15%
 
TNGX Tango Therapeutics, Inc.
1.1400
+3.64%
 
EVAX Evaxion Biotech A/S
1.4900
+1.36%